| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $32.2M | +3.4% |
| SG&A Expense | $16.5M | +18.6% |
| Operating Income | -$48.7M | -8.1% |
| Interest Expense | $1.8M | -52.8% |
| Net Income | -$40.2M | +9.9% |
| EPS (Basic) | -$3.68 | +64.3% |
| EPS (Diluted) | -$3.68 | +64.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.2M | +25.3% |
| Short-term Investments | $131.9M | +1736.0% |
| Current Assets | $153.0M | +549.7% |
| Total Assets | $155.9M | +451.3% |
| Current Liabilities | $11.8M | -62.9% |
| Total Liabilities | $13.5M | -61.8% |
| Stockholders' Equity | $142.4M | +2162.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.8M | -15.8% |
| Investing Cash Flow | -$121.3M | -440.4% |
| Financing Cash Flow | $166.6M | +6005.9% |